Teladoc Health, Inc. (TDOC) — SEC Financial Statements & Analysis

Teladoc Health, Inc. (TDOC) is a services-offices & clinics of doctors of medicine company, incorporated in DE. Teladoc Health, Inc. trades on NYSE as: TDOC. Teladoc Health, Inc. (TDOC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-10-29. Based on that filing, Teladoc Health, Inc. carries a market cap of $1.05B, a P/E ratio of -6.81x, a P/B ratio of 0.81x, a P/S ratio of 0.43x, an enterprise value of $1.20B, and an EV/EBITDA multiple of 6.15x. On profitability, it posts a gross margin of 68.57%, an operating margin of -6.60%, a net margin of -6.27%, a Return on Equity (ROE) of -11.52%, a Return on Assets (ROA) of -5.48%, and a Return on Invested Capital (ROIC) of -9.93%. Per share, it reports EPS of $-0.85, diluted EPS of $-0.85, free cash flow per share of $1.44, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.38% year-over-year, net income growth of -30.76% year-over-year, and EPS growth of -32.64% year-over-year. On the balance sheet, it maintains a current ratio of 0.87x, a quick ratio of 0.76x, working capital of $-189.49M, a debt-to-equity ratio of 1.14x, a debt ratio of 0.53, an interest coverage ratio of -8.00x, free cash flow of $261.96M (TTM), and net debt of $147.68M. Figures sourced from SEC EDGAR.

Market Cap

$1.05B

P/E TTM

-6.81x

EPS TTM

$-0.85

P/B TTM

0.81x

ROE TTM

-11.52%

ROA TTM

-5.48%

Debt To Equity

1.14x

Free Cash Flow TTM

$261.96M

Net Revenue TTM Growth 1Y

-2.38%

Data as of 2026-09-30 · Source: SEC EDGAR